Avinger's Next-Generation Pantheris Image-Guided Atherectomy Device Receives CE Mark Approval

 

December 20, 2017—Avinger, Inc. announced European CE Mark approval for its next-generation Pantheris Lumivascular image-guided atherectomy system for the treatment of peripheral artery disease (PAD). The device features a simplified single balloon system for both apposition of the device and occlusion of blood flow, a stiffer shaft for increased pushability, a more robust nose cone with the option for more tissue storage capacity, and an enhanced cutter design.

According to the company, Lumivascular technology allows physicians to see from inside the artery during an atherectomy procedure by using optical coherence tomography (OCT) imaging that is displayed on Avinger’s Lightbox console. Compared with X-ray imaging, the Lumivascular approach with real-time OCT allows physicians to more accurately navigate devices and treat PAD lesions, without exposing health care workers and patients to ionizing radiation.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.